These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 36201124)

  • 1. Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
    Isnardi CA; Roberts K; Saurit V; Petkovic I; Báez RM; Quintana R; Tissera Y; Ornella S; D Angelo Exeni ME; Pisoni CN; Castro Coello VV; Berbotto G; Haye Salinas MJ; Velozo E; Reyes Torres ÁA; Tanten R; Zelaya MD; Gobbi C; Alonso CG; de Los Ángeles Severina M; Vivero F; Paula A; Cogo AK; Alle G; Pera M; Nieto RE; Cosatti M; Asnal C; Pereira D; Albiero JA; Savio VG; Maldonado FN; Gamba MJ; Germán NF; Baños A; Gallino Yanzi J; Gálvez Elkin MS; Morbiducci JS; Martire MV; Maldonado Ficco H; Schmid MM; Villafañe Torres JA; de Los Ángeles Correa M; Medina MA; Cusa MA; Scafati J; Agüero SE; Lloves Schenone NM; Soriano ER; Graf C; Pons-Estel BA; Gomez G; Landi M; De la Vega MC; Pons-Estel GJ;
    Clin Rheumatol; 2023 Feb; 42(2):563-578. PubMed ID: 36201124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the Use of Immunosuppressive Drugs Impact on SARS-CoV-2 Infection Outcome? Data From A National Cohort of Patients With Immune-Mediated Inflammatory Diseases (SAR-COVID Registry).
    Isnardi CA; Soriano ER; Graf C; de la Vega MC; Pons-Estel BA; Roberts K; Quintana R; Gomez G; Yazdany J; Saurit V; Báez RM; Coello VVC; Pisoni CN; Berbotto G; Vivero F; Zelaya MD; Haye Salinas MJ; Reyes Torres ÁA; Ornella S; Nieto RE; Maldonado FN; Gamba MJ; Severina MLÁ; Tissera Y; Alba P; Cogo AK; Alle G; Gobbi C; Baños A; Velozo E; Pera M; Tanten R; Albiero JA; Maldonado Ficco H; Martire MV; Elkin MSG; Cosatti M; Cusa MA; Pereira D; Savio VG; Pons-Estel GJ
    J Clin Rheumatol; 2023 Mar; 29(2):68-77. PubMed ID: 36454054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
    Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
    Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for hospitalization or mortality for COVID-19 in patients with rheumatic diseases: Results of a nationwide JCR COVID-19 registry in Japan.
    Oku K; Kimoto Y; Horiuchi T; Yamamoto M; Kondo Y; Okamoto M; Atsumi T; Takeuchi T
    Mod Rheumatol; 2023 Jul; 33(4):768-776. PubMed ID: 36066189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
    Gianfrancesco M; Hyrich KL; Al-Adely S; Carmona L; Danila MI; Gossec L; Izadi Z; Jacobsohn L; Katz P; Lawson-Tovey S; Mateus EF; Rush S; Schmajuk G; Simard J; Strangfeld A; Trupin L; Wysham KD; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Yazdany J; Machado PM; Robinson PC;
    Ann Rheum Dis; 2020 Jul; 79(7):859-866. PubMed ID: 32471903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases.
    Clemente D; Udaondo C; de Inocencio J; Nieto JC; Del Río PG; Fernández AG; Palomo JA; Bachiller-Corral J; Lopez Robledillo JC; Millán Longo C; Leon L; Abasolo L; Boteanu A
    Pediatr Rheumatol Online J; 2021 Nov; 19(1):162. PubMed ID: 34838054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
    Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
    Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
    Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
    Bakasis AD; Mavragani CP; Boki KA; Tzioufas AG; Vlachoyiannopoulos PG; Stergiou IE; Skopouli FN; Moutsopoulos HM
    J Autoimmun; 2021 Sep; 123():102687. PubMed ID: 34311142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.
    Strangfeld A; Schäfer M; Gianfrancesco MA; Lawson-Tovey S; Liew JW; Ljung L; Mateus EF; Richez C; Santos MJ; Schmajuk G; Scirè CA; Sirotich E; Sparks JA; Sufka P; Thomas T; Trupin L; Wallace ZS; Al-Adely S; Bachiller-Corral J; Bhana S; Cacoub P; Carmona L; Costello R; Costello W; Gossec L; Grainger R; Hachulla E; Hasseli R; Hausmann JS; Hyrich KL; Izadi Z; Jacobsohn L; Katz P; Kearsley-Fleet L; Robinson PC; Yazdany J; Machado PM;
    Ann Rheum Dis; 2021 Jul; 80(7):930-942. PubMed ID: 33504483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry.
    Kihara M; Sugihara T; Asano J; Sato M; Kaneko H; Muraoka S; Ohshima S; Nanki T
    Clin Rheumatol; 2022 Dec; 41(12):3661-3673. PubMed ID: 35974224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population.
    Arleo T; Tong D; Shabto J; O'Keefe G; Khosroshahi A
    Clin Rheumatol; 2021 Jul; 40(7):2633-2642. PubMed ID: 33420870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients.
    FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors
    Ann Rheum Dis; 2021 Apr; 80(4):527-538. PubMed ID: 33268442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry.
    Gianfrancesco MA; Leykina LA; Izadi Z; Taylor T; Sparks JA; Harrison C; Trupin L; Rush S; Schmajuk G; Katz P; Jacobsohn L; Hsu TY; D'Silva KM; Serling-Boyd N; Wallwork R; Todd DJ; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Machado PM; Robinson PC; Yazdany J;
    Arthritis Rheumatol; 2021 Mar; 73(3):374-380. PubMed ID: 33146001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Among Patients With Inflammatory Rheumatic Diseases.
    Esatoglu SN; Tascilar K; Babaoğlu H; Bes C; Yurttas B; Akar S; Pehlivan O; Akleylek C; Tecer D; Seyahi E; Yuce-Inel T; Alpay-Kanitez N; Bodakci E; Tekgoz E; Colak S; Bolek EC; Koca SS; Kalyoncu U; Icacan OC; Ugurlu S; Oz HE; Hamuryudan V; Hatemi G;
    Front Immunol; 2021; 12():651715. PubMed ID: 33936073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated With Mortality in Patients With Immune-Mediated Rheumatic Diseases and COVID-19 From Latin America: Data From Argentina, Mexico, and Brazil.
    Isnardi CA; Alpizar-Rodriguez D; Calderaro DC; Marques CDL; Pons-Estel GJ; Xavier RM; Saurit V; Pisoni CN; Tissera YS; D'Angelo Exeni ME; Alba P; Pereira D; Gobbi CA; Gamba MJ; Alfaro MA; Virasoro BM; Colunga-Pedraza IJ; Irazoque-Palazuelos F; Reyes-Cordero G; Rodriguez-Reyna TS; Veloz-Aranda JA; Skinner-Taylor CM; Juárez-Mora IM; Silveira LH; Pacheco Tena CF; Xibille-Friedmann DX; Ferreira GA; Kakehasi AM; Pinheiro MM; Gomides APM; Pileggi GCS; da Mota LMH; Dos Reis-Neto ET; Ribeiro SLE; de Azevedo Valadares LD; Martínez-Martínez MU
    J Clin Rheumatol; 2024 Jan; 30(1):e9-e17. PubMed ID: 37936271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe COVID-19 in patients with immune-mediated rheumatic diseases: A stratified analysis from the SORCOM multicentre registry.
    Boteanu A; Leon L; Pérez Esteban S; Rabadán Rubio E; Pavía Pascual M; Bonilla G; Bonilla González-Laganá C; García Fernandez A; Recuero Diaz S; Ruiz Gutierrez L; Sanmartín Martínez JJ; de la Torre-Rubio N; Nuño L; Sánchez Pernaute O; Del Bosque I; Lojo Oliveira L; Rodríguez Heredia JM; Clemente D; Abasolo L; Bachiller-Corral J
    Mod Rheumatol; 2023 Dec; 34(1):97-105. PubMed ID: 36516217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
    Hasseli R; Mueller-Ladner U; Hoyer BF; Krause A; Lorenz HM; Pfeil A; Richter J; Schäfer M; Schmeiser T; Strangfeld A; Schulze-Koops H; Voll RE; Specker C; Regierer AC
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33479021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID-19 Global Rheumatology Alliance (C19-GRA) physician registry.
    Abutiban F; Saleh K; Hayat S; Tarakmah H; Al-Herz A; Ghanem A
    Int J Rheum Dis; 2022 Jul; 25(7):743-754. PubMed ID: 35543332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.